- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07416643
The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans (AcaciaGlu)
February 10, 2026 updated by: Mai Khatib, King Abdulaziz University
The Role of Incorporating Acacia Gum in Foods on Glucose Homeostasis in Healthy Humans: a Pilot Study
Abnormal postprandial blood glucose (PPG) is considered as a strong predictor for developing metabolic diseases worldwide.
Nowadays, little understanding is available on how a carbohydrate-rich food matrix and the starch structures within interact with the gastrointestinal tract to help in controlling PPG.
In this investigation, the use Acacia gum enriched flour will be used to explore the effect of adding the gum as food supplement on PPG in healthy humans.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jeddah, Saudi Arabia
- King Fahd Medical Research center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male and female self-reported healthy volunteers (aged 18 to 40 years)
- Normal to overweight individuals (body mass index (BMI) 18.5-30 kg/m2) o BMI is equal to body weight (kg) divided by height squared (m2)
Exclusion Criteria:
- History of substance abuse
- Excessive alcohol intake
- Pregnancy
- Diabetes
- Cardiovascular disease
- Cancer
- Any gastrointestinal disease e.g. irritable bowel syndrome or inflammatory bowel disease
- Kidney disease
- Liver disease
- Pancreatitis
- Use of medications likely to interfere with energy metabolism, appetite regulation and hormonal balance, including: anti-inflammatory drugs or steroids, antibiotics, androgens, phenytoin, erythromycin or thyroid hormones.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acacia gum incorporated biscuits
|
incorporating acacia gum flour into commonly consume foods
|
|
No Intervention: control biscuits
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
postprandial blood glucose
Time Frame: 0 minutes and postprandial timepoints: 15 minutes, 30 minutes, 60 minutes,120 minutes,180 minutes
|
0 minutes and postprandial timepoints: 15 minutes, 30 minutes, 60 minutes,120 minutes,180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Actual)
August 30, 2023
Study Completion (Actual)
September 30, 2023
Study Registration Dates
First Submitted
January 30, 2026
First Submitted That Met QC Criteria
February 10, 2026
First Posted (Actual)
February 18, 2026
Study Record Updates
Last Update Posted (Actual)
February 18, 2026
Last Update Submitted That Met QC Criteria
February 10, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 286-22
- 596-290-1443 (Other Grant/Funding Number: The Deanship of Scientific Research (DSR) at King Abdulaziz University (KAU), Jeddah, Saudi Arabia)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Adult Subjects
-
Shanghai Henlius BiotechNot yet recruitingHealth Adult SubjectsChina
-
Biotech Pharmaceutical Co., Ltd.Not yet recruiting
-
Genrix (Shanghai) Biopharmaceutical Co., Ltd.RecruitingHealth Adult SubjectsChina
-
Colgate PalmoliveCompletedHealth Adult SubjectsUnited States
-
Poznan University of Physical EducationCompletedHealth Adult SubjectsPoland
-
BiogenCelerion; Q2 SolutionsCompleted
-
ZHANG JiaqiRecruitingHealth Adult SubjectsChina
-
Nanjing Nutrabuilding Bio-tech Co., Ltd.Biofortis, Merieux NutriSciencesNot yet recruitingHealth Adult SubjectsUnited States
-
Nigde Omer Halisdemir UniversityActive, not recruiting